205 related articles for article (PubMed ID: 2882289)
1. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.
Flores J; Perez-Schael I; Gonzalez M; Garcia D; Perez M; Daoud N; Cunto W; Chanock RM; Kapikian AZ
Lancet; 1987 Apr; 1(8538):882-4. PubMed ID: 2882289
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine.
Perez-Schael I; Garcia D; Gonzalez M; Gonzalez R; Daoud N; Perez M; Cunto W; Kapikian AZ; Flores J
J Med Virol; 1990 Mar; 30(3):219-29. PubMed ID: 2160516
[TBL] [Abstract][Full Text] [Related]
4. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G
Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
[TBL] [Abstract][Full Text] [Related]
7. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
[TBL] [Abstract][Full Text] [Related]
8. Rotavirus vaccines and vaccination in Latin America.
Linhares AC; Bresee JS
Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea.
Vesikari T; Ruuska T; Delem A; André FE; Beards GM; Flewett TH
Acta Paediatr Scand; 1991 Feb; 80(2):173-80. PubMed ID: 1852084
[TBL] [Abstract][Full Text] [Related]
10. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela.
Flores J; Daoud G; Daoud N; Puig M; Martinez M; Perez-Schael I; Shaw R; Greenberg HB; Midthun K; Kapikian AZ
Pediatr Infect Dis J; 1988 Nov; 7(11):776-80. PubMed ID: 2852792
[TBL] [Abstract][Full Text] [Related]
11. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
Losonsky GA; Rennels MB; Kapikian AZ; Midthun K; Ferra PJ; Fortier DN; Hoffman KM; Baig A; Levine MM
Pediatr Infect Dis; 1986; 5(1):25-9. PubMed ID: 3003715
[TBL] [Abstract][Full Text] [Related]
12. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants.
Hanlon P; Hanlon L; Marsh V; Byass P; Shenton F; Hassan-King M; Jobe O; Sillah H; Hayes R; M'Boge BH
Lancet; 1987 Jun; 1(8546):1342-5. PubMed ID: 2884455
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
14. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
[TBL] [Abstract][Full Text] [Related]
15. Field trial of rhesus rotavirus vaccine in infants.
Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
[TBL] [Abstract][Full Text] [Related]
16. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
Joensuu J; Koskenniemi E; Pang XL; Vesikari T
Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
[TBL] [Abstract][Full Text] [Related]
17. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
[TBL] [Abstract][Full Text] [Related]
19. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population.
Santosham M; Letson GW; Wolff M; Reid R; Gahagan S; Adams R; Callahan C; Sack RB; Kapikian AZ
J Infect Dis; 1991 Mar; 163(3):483-7. PubMed ID: 1995721
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus specific breast milk antibody in two populations and possible correlates of protection.
Losonsky GA; D'Alessandra de Rimer H
Adv Exp Med Biol; 1991; 310():265-9. PubMed ID: 1667067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
